12 Health Care Stocks Moving In Monday's Pre-Market Session
$ACGN
$APLS
$GRCL
$HCM
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Biotechnology: Pharmaceutical Preparations
Health Care
Gainers
- Vistagen Therapeutics (NASDAQ:VTGN) stock increased by 187.5% to $4.83 during Monday's pre-market session. The market value of their outstanding shares is at $38.5 million.
- Nektar Therapeutics (NASDAQ:NKTR) stock moved upwards by 33.87% to $0.71. The company's market cap stands at $134.9 million.
- Tabula Rasa HealthCare (NASDAQ:TRHC) stock increased by 32.05% to $10.34. The market value of their outstanding shares is at $277.6 million. The company's, Q2 earnings came out today.
- T2 Biosystems (NASDAQ:TTOO) stock moved upwards by 25.92% to $0.31. The market value of their outstanding shares is at $91.3 million. As per the press release, Q2 earnings came out today.
- Gracell Biotechnologies (NASDAQ:GRCL) shares rose 17.25% to $4.01. The market value of their outstanding shares is at $271.5 million.
- Protalix BioTherapeutics (AMEX:PLX) shares rose 16.25% to $1.93. The market value of their outstanding shares is at $138.1 million. The company's, Q2 earnings came out today.
Losers
- Sage Therapeutics (NASDAQ:SAGE) stock declined by 48.5% to $18.6 during Monday's pre-market session. The company's market cap stands at $1.1 billion. As per the press release, Q2 earnings came out today.
- Tivic Health Systems (NASDAQ:TIVC) stock declined by 40.17% to $0.04. The company's market cap stands at $4.8 million.
- Aceragen (NASDAQ:ACGN) stock declined by 30.3% to $0.52. The company's market cap stands at $4.3 million.
- Quantum-Si (NASDAQ:QSI) shares decreased by 25.08% to $2.54. The company's market cap stands at $359.4 million. As per the press release, Q2 earnings came out today.
- Apellis Pharmaceuticals (NASDAQ:APLS) shares declined by 15.41% to $20.75. The market value of their outstanding shares is at $2.4 billion.
- HUTCHMED (China) (NASDAQ:HCM) shares declined by 13.6% to $14.24. The company's market cap stands at $2.4 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.